Evidence supporting the use of: Antioxidant (unspecified)
For the health condition: Parkinson's Disease

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Antioxidants have been investigated as a potential supportive therapy in Parkinson's Disease (PD) due to the role of oxidative stress in the pathogenesis of the condition. Oxidative stress refers to cellular damage caused by free radicals, and several studies have shown that markers of oxidative damage are elevated in the brains of people with PD. This has led to the hypothesis that antioxidants—substances that neutralize free radicals—might slow disease progression or alleviate symptoms.

While some antioxidants like vitamin E, vitamin C, coenzyme Q10, and others have been explored in clinical trials, the results have been mixed or negative. For example, large randomized controlled trials with vitamin E and coenzyme Q10 did not demonstrate a significant benefit in slowing the progression of PD. Systematic reviews and meta-analyses generally conclude that, as of now, there is insufficient evidence to recommend antioxidant supplementation as an effective treatment for Parkinson's Disease. However, research into specific antioxidants and their mechanisms continues, and dietary intake of antioxidants as part of a healthy diet is sometimes encouraged, though not as a replacement for established therapies.

In summary, while there is a scientific rationale and substantial research interest in the use of antioxidants for PD, clinical evidence supporting their efficacy is limited and does not support their use as a primary or adjunctive therapy at this time.

More about Antioxidant (unspecified)
More about Parkinson's Disease

Products containing Antioxidant (unspecified)

We currently have no products on Vitabase that contain this ingredient.